Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00053989 · ADVERSE EVENTS

Adverse events

NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders · Source last updated 2020-02-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.

Collection time frame
100 days
Other-event reporting threshold
0%

SAE=died before absolute neutrophil count recovery (DBE) or survived to day +28 without absolute neutrophil count recovery (FTE) AE=overall grade III-IV acute GVHD

Participants affected / participants at risk, as reported
Safety groupSerious eventsOther eventsDeaths
All Patients

All patients enrolled on study

3 / 416 / 418 / 41

Group identifiers: EG000: All Patients

Serious adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

  1. assessment Type
    SYSTEMATIC_ASSESSMENT
    notes
    died before absolute neutrophil count recovery (DBE) or survived to day +28 without absolute neutrophil count recovery (FTE)
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    Serious
    stats
    1. group Id
      EG000
      num Affected
      3
      num At Risk
      41
      num Events
      3
    term
    DBE/FTE

Other reported adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

  1. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Immune system disorders
    source Vocabulary
    Other
    stats
    1. group Id
      EG000
      num Affected
      6
      num At Risk
      41
      num Events
      6
    term
    acute GVHD grade III-IV
Complete source fields
description
SAE=died before absolute neutrophil count recovery (DBE) or survived to day +28 without absolute neutrophil count recovery (FTE) AE=overall grade III-IV acute GVHD
event Groups
  1. deaths Num Affected
    8
    deaths Num At Risk
    41
    description
    All patients enrolled on study
    id
    EG000
    other Num Affected
    6
    other Num At Risk
    41
    serious Num Affected
    3
    serious Num At Risk
    41
    title
    All Patients
frequency Threshold
0
other Events
  1. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Immune system disorders
    source Vocabulary
    Other
    stats
    1. group Id
      EG000
      num Affected
      6
      num At Risk
      41
      num Events
      6
    term
    acute GVHD grade III-IV
serious Events
  1. assessment Type
    SYSTEMATIC_ASSESSMENT
    notes
    died before absolute neutrophil count recovery (DBE) or survived to day +28 without absolute neutrophil count recovery (FTE)
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    Serious
    stats
    1. group Id
      EG000
      num Affected
      3
      num At Risk
      41
      num Events
      3
    term
    DBE/FTE
time Frame
100 days

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice